Five Prime Therapeutics' Project Finance Round

Five Prime Therapeutics raised a round of funding on February 25, 2010. Investors include Centocor.

Five Prime Therapeutics is a clinical-stage biotechnology company with a pipeline of antibodies and ligand traps for cancer, autoimmunity and respiratory diseases. FivePrime has differentiated discove…

Articles about Five Prime Therapeutics' Project Finance Round: